Delivery Order SPE2DB22D2206-SPE2DB24FGL65
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,389,740 units of Sandostatin LAR Depot 20 mg pharmaceutical kits. The $9,741.90 firm fixed price contract has an ultimate completion date of April 25, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,093.99 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Sandostatin LAR Depot 10 mg pharmaceutical kits. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract, valued at $2,648.30, to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Sandostatin LAR Depot 20 mg kits. This delivery order is placed under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,914.52 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Sandostatin LAR Depot 30 mg kits. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00 and in effect through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 30 mg kits of the pharmaceutical product Sandostatin LAR Depot. The $6,562.82 award has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp is also the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA, which serves as the primary vehicle for the company to deliver...
- The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract worth $33,187.08 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a period of performance through March 18, 2025, is for the supply of Sandostatin LAR Depot 30 mg kits, a specialty medication used in the treatment of various medical conditions. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sandostatin LAR Depot 30 mg kits. The $17,709.77 firm fixed-price delivery order, which is not set aside, has an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, that serves as a comprehensive...
- This delivery order award, valued at $27,818.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 30 mg Kits. The contract has an ultimate completion date of September 13, 2024. AmerisourceBergen, as a major pharmaceutical distributor, holds multiple indefinite delivery contracts (IDCs) with DLA and other federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of medical commodities....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,336.65 firm fixed-price delivery order contract is for the provision of Sandostatin LAR Depot 20 mg kits, a specialty medication. The contract has an ultimate completion date of November 3, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,211.41 Firm Fixed Price delivery order is for the supply of Sandostatin LAR Depot 20 mg kits. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGL65Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,648.30 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the delivery of Sandostatin LAR Depot, a specialty pharmaceutical product, with a completion date of April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 4/3/24 |